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Background: Nerve injury may induce neuropathic pain. In studying the mechanisms of orofa-
cial neuropathic pain, attention has been paid to the plastic changes that occur in the trigeminal 
ganglia (TGs) and nucleus in response to an injury of the trigeminal nerve branches. Previous 
studies have explored the impact of sciatic nerve injury on dorsal root ganglia (DRGs) and it 
has shown dramatic changes in the expression of multiple biomarkers. In large, the changes 
in biomarker expression in TGs after trigeminal nerve injury are similar to that in DRGs after 
sciatic nerve injury. However, important differences exist. Therefore, there is a need to study 
the plasticity of biomarkers in TGs after nerve injury in the context of the development of 
neuropathic pain-like behaviors.
Aim: The aim of this study was to investigate the plasticity of biomarkers associated with 
chronic persistent pain in TGs after trigeminal nerve injury.
Materials and methods: To mimic the chronic nature of the disorder, we used an intraoral 
procedure to access the infraorbital nerve (ION) and induced a nerve injury in mice. Immuno-
histochemistry and quantification were used for revealing the expression level of each biomarker 
in TGs after nerve injury.
Results: Two weeks after partial ION injury, immunohistochemistry results showed strongly 
upregulated expressions of activating transcription factor 3 and neuropeptide Y (NPY) in the 
ipsilateral TGs. Microglial cells were also activated after nerve injury. In regard to positive neu-
ronal profile counting, however, no significant difference in expression was observed in galanin, 
substance P, calcitonin gene-related peptide, neuronal nitric oxide synthase, phosphorylated 
AKT, or P2X3 in ipsilateral TGs when compared to contralateral TGs.
Conclusion: In this study, the expression and regulation of biomarkers in TGs have been 
observed in response to trigeminal nerve injury. Our results suggest that NPY and Iba1 might 
play crucial roles in the pathogenesis of orofacial neuropathic pain following this type of injury. 
Further investigations on the relevance of these changes may help to target suitable treatment 
possibilities for trigeminal neuralgia.
Keywords: infraorbital nerve, orofacial pain, sensory neurons, neuropeptides, animal model
Introduction
Trigeminal neuralgia is regarded as being one of the most painful diseases known.1 
Pain resulting from this disease impairs patients’ mood, quality of life, daily life activi-
ties, and work performance.2 Known factors that can cause trigeminal neuralgia are 
injury, inflammation, and vascular compression of the trigeminal nerve.3,4 However, 
the mechanisms of trigeminal neuralgia are still poorly understood.
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Sensory neuron plasticity after peripheral injury is con-
sidered important for understanding the development of 
chronic persistent pain.5 Studies have revealed that the impact 
that sciatic nerve injury has on dorsal root ganglia (DRGs) 
causes dramatic changes in the expression of certain peptides, 
more specifically excitatory peptides such as substance P 
(SP) and calcitonin gene-related peptide (CGRP), as well 
as inhibitory and excitatory neuropeptides such as galanin 
(GAL) and neuropeptide Y (NPY).6,7 Neuronal nitric oxide 
synthase (nNOS) and P2X3 are also known to play a role 
in nociception.8,9 Phosphorylated AKT (pAKT) is believed 
to have neuroprotective effects and can be regulated in sen-
sory ganglia after injury.5,10,11 All of these changes may have 
implications in the generation and modulation of neuropathic 
pain.12 To our knowledge, only a limited number of studies 
have been conducted to examine neuronal plasticity of the 
trigeminal ganglion (TG) following trigeminal nerve injury. 
These studies show that the changes in neuropeptide expres-
sion of TGs after trigeminal nerve injury are similar to DRGs 
after sciatic nerve injury.13,14 However, important differences 
exist. For example, GAL is markedly upregulated in DRGs 
after sciatic nerve injury,15 whereas GAL expression in TGs 
has been inconclusive, with results showing an increase, no 
change, or even decrease in expression after facial nerve 
injury.13,16 Interestingly, systematic studies have not been 
conducted on the expression of neuropeptides in TGs after 
nerve injury in the context of the development of neuropathic 
pain-like behaviors, as in the case of sciatic nerve injury.17
Recently, several animal models have been developed 
to examine trigeminal nerve injury, inflammation, and tri-
geminal nerve root compression.18–21 Among these models, 
the infraorbital nerve (ION) constriction model of trigeminal 
neuralgia has been performed in both rats and mice.22–24 
Interestingly, animal models of trigeminal neuralgia obtained 
by a chronic constriction injury of ION are shown to share 
many characteristics with clinical disorders in humans.25,26
Because pain-related biomarkers give accurate signals, 
observing and understanding their changes may help us find 
potential targets for treating painful diseases. In this study, 
we investigated the expression of several biomarkers in TGs 
following trigeminal nerve injury. Expression and regulation 
of activating transcription factor 3 (ATF3), NPY, Iba1, GAL, 
CGRP, SP, nNOS, pAKT, and P2X3 were examined in a 
modified mouse model of trigeminal neuralgia.
Materials and methods
Animals
Adult male C57BL/6J Bommince mice (A/S Bomholtgaard, 
Ry, Denmark) weighing 28–30 g were used in this study. 
All animals were kept under standard conditions on a 12-h 
day/night cycle with free access to food and water. The 
experiments were carried out according to the International 
Association for the Study of Pain Guidelines for the Use 
of Animals in Research and were approved by Karolinska 
Institutet ethics committee (registration number: N48/13).
Operation
Mice were anesthetized with isoflurane, received a transec-
tion to the left ION, and the contralateral side (right side) 
was used as a control. The surgery was performed intraorally, 
which allowed the hair on the snout and the vibrissae to be 
kept intact. A transection of ~0.5 cm was made unilaterally 
along the left gingivobuccal margin. The transection began 
at ~0.1 cm proximal to the first molar. The modification of 
surgery is based on two previously published studies.27,28 The 
mice were sacrificed 2 weeks after surgery.
Immunohistochemistry
All operated animals were deeply anesthetized with sodium 
pentobarbital (50 mg/kg, i.p.) and transcardially perfused with 
20 mL of warm saline (0.9%; 37°C), followed by 20 mL of 
a warm mixture of paraformaldehyde (4%; 37°C) with 0.4% 
picric acid in 0.16 M phosphate buffer (pH 7.2) and then by 
50 mL of the same, but ice-cold fixative. Both the ipsilateral 
and contralateral TGs were dissected out and postfixed in 
the same fixative for 90 min at 4°C and subsequently stored 
in 10% sucrose in phosphate-buffered saline (PBS; pH 7.4) 
containing 0.01% sodium azide (Sigma-Aldrich Co., St Louis, 
MO, USA) and 0.02% bacitracin (Sigma-Aldrich Co.) at 4°C 
for 2 days. Tissues were embedded with optimum cutting 
temperature compound (Tissue-Tek; Miles Laboratories, 
Elkhart, IN, USA), frozen and cut in a cryostat (Microm, 
Heidelberg, Germany) at 14 μm thickness, and then mounted 
onto chrome-alum-gelatin-coated slides. Thaw-mounted 
sections were dried at room temperature (RT) for 30 min 
and rinsed with PBS for 15 min. Sections were incubated 
for 24 h at 4°C in a humid chamber with rabbit anti-ATF3 
(1:4,000; D1610, Santa Cruz Biotechnology, Dallas, TX, 
USA), NPY (1:8,000),29 rabbit anti-GAL (1:8,000),30 rabbit 
anti-SP (1:4,000),31 rabbit anti-CGRP (1:10,000),32 sheep 
anti-nNOS (1:4,000),32 rabbit anti-pAKT (1:4,000; G7441, 
Promega Corporation, Madison, WI, USA), and rabbit 
anti-P2X3 (1:4,000)33 antisera diluted in PBS containing 
0.2% (w/v) bovine serum albumin and 0.03% Triton X-100. 
Immunoreactivity was visualized using the tyramide signal 
amplification system (TSA Plus; NEN Life Science Products, 
Boston, MA, USA). Briefly, the slides were rinsed with Tris-































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1




Neuronal plasticity of TGs in mice following nerve injury
0.15 M NaCl; 0.05% Tween-20) for 15 min at RT, blocked 
with Tris-HCL/NaCL/DuPont blocking reagent (TNB) buf-
fer (0.1 M Tris–HCl; pH 7.5; 0.15 M NaCl; 0.5% DuPont 
blocking reagent) for 30 min at RT followed by a 30-min 
incubation with horseradish peroxidase-labeled swine anti-
rabbit and/or anti-sheep antibody (1:200; Dako Denmark A/S, 
Glostrup, Denmark) diluted in TNB buffer. After a quick wash 
(15 min) in TNT buffer, all sections were exposed to biotinyl 
tyramide-fluorescein (1:100) diluted in amplification diluent 
for 10 min, and finally washed in TNT buffer for 30 min (all 
steps performed at RT). Sections to be used for profile counts 
(with nucleus) were counterstained for 8–10 min in 0.001% 
(w/v) propidium iodide (PI; Sigma-Aldrich Co.) in PBS, 
rinsed twice for 5 min in PBS, and mounted with glycerol/
PBS (9:1) containing 2.5% DABCO (Sigma-Aldrich Co.).
Image analysis and quantification
Specimens were analyzed on a Bio-Rad Radiance Plus confo-
cal scanning microscope (Bio-Rad, Hemel Hempstead, UK) 
installed on a 710 LSM laser-scanning microscope equipped 
with ×10 (0.5 numerical aperture [NA]), ×20 (0.75 NA), 
and ×60 (1.40 NA) oil objectives. Fluorescein labeling was 
excited using the 488 nm line of the argon ion laser and 
detected after passing a HQ 530/60 (Bio-Rad Laboratories 
Inc.) emission filter. All the slides were scanned in a series 
of 1 μm thick optical sections.
To determine the percentage of immunoreactive (IR) 
neuronal profiles (NPs), the counting was performed on 
14-µm-thick sections, and every fifth section was selected. 
The total number of immunopositive NPs was divided by 
the total number of PI-stained NPs in the TG sections, and 
the  percentage of positive NPs was calculated. Four to eight 
sections of each TG from five animals in each group (i.e., ipsi-
lateral and contralateral groups) were included in the analysis, 
and 1,200–1,800 NPs were counted in each ganglion.
Statistical analysis
Unpaired Student’s t-test was used for the comparison of 
difference between ipsilateral and contralateral expression 
of each biomarker. p<0.05 was taken as the criterion for 
statistical significance (*p<0.05, **p<0.01, and ***p<0.001).
Results
ATF3 expression in TGs after ION injury
ATF3-IR NPs were almost undetectable in the contralateral 
TGs 2 weeks after partial ION injury. However, a strong 
upregulation of ATF3-IR NPs was seen in the ipsilateral TGs, 
as shown in Figure 1A, B versus C and Figure 2 (0.9±0.2% 
vs. 30.1±5.8%; p<0.001), mainly in the maxillary infraorbital 
neurons (Figure 1A; red box).
Expression of biomarkers in TGs after 
ION injury
In the contralateral TGs, very few NPs were NPY positive 
(1.8±0.9%), while a dramatic increased expression of NPY-
positive NPs was seen in the ipsilateral TGs (12.9±5.6%; 
p<0.01; Figures 2–4A and B). This increase is ~10-fold when 
compared to the control. Regarding GAL expression, more 
positive NPs were found in the ipsilateral TGs, but this increase 
in expression was not statistically significant (11.5±5.8% vs. 
13±4.8%; p>0.05; Figures 2 and 3). No significant difference 
was detected between the ipsilateral and contralateral TGs for 
Figure 1 Expression of ATF3-LI in TGs 2 weeks after partial ION transection.
Notes: (A) ATF3-LI is mainly seen in the infraorbital neurons (red box) in ipsilateral TGs. (B and C) High magnification micrographs show the expression of ATF3-IR neurons 
in ipsilateral (B) and contralateral (C) TGs. Scale bars indicate 250 μm (A) and 50 μm (B and C).
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Figure 2 Percentage of positive NPs in contralateral and ipsilateral TGs 2 weeks after partial ION transection.
Note: The columns represent contralateral (blue) and ipsilateral (red) TGs, respectively (n=5 in each group, **p<0.01, ***p<0.001).
Abbreviations: ATF3, activating transcription factor 3; CGRP, calcitonin gene-related peptide; GAL, galanin; ION, infraorbital nerve; nNOS, neuronal nitric oxide synthase; 









































































































Figure 3 Immunofluorescent micrographs show the expression of biomarkers in contralateral (top panel) and ipsilateral (bottom panel) TGs 2 weeks after partial ION 
transection.
Notes: Sections were incubated with antisera of Iba1, CGRP, SP, GAL, NPY, P2X3, nNOS, and pAKT, respectively. Scale bar indicates 100 μm.
Abbreviations: CGRP, calcitonin gene-related peptide; ION, infraorbital nerve; nNOS, neuronal nitric oxide synthase; NPY, neuropeptide Y; pAKT, phosphorylated AKT; 















CGRP SP GAL NPY P2X3 nNOS pAKT
CGRP (43.7±9.9% vs. 40.9±13.0%; Figures 2, 3, and 5A), 
SP (32.2±3.7% vs. 31.6±9.1%;  Figures 2, 3, and 5B), P2X3 
(60.4±15.8% vs. 54.0±1.3%; Figures 2 and 3), or nNOS 
(15.9±6.0% vs. 18.6±9.3%; Figures 2 and 3), respectively. 
pAKT-like immunoreactivity (pAKT-LI) was seen in many 
neurons in intact TGs ( Figure 5C), especially small-sized 
ones. pAKT had a relatively high intensity in ipsilateral TGs 
but the percentage of positive-NPs remained the same 2 weeks 
after ION injury (46.6±9.2% vs. 51.5±7.1%; Figures 2 and 3). 
Iba1, a marker for activated microglial cells, was activated in 
the ipsilateral TGs as compared to contralateral ones 2 weeks 
after partial ION injury (Figures 3 and 4C–F). The expres-
sion of Iba1-LI in the contralateral TGs presented a typical 
resting microglial morphology (Figures 3 and 4C and E). By 
contrast, the enlarged and amoeboid morphological features 
of activated microglia cell bodies were seen in the ipsilateral 
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Neuronal plasticity of TGs in mice following nerve injury
Figure 4 Expression of NPY and Iba1 in ipsilateral and contralateral TGs 2 weeks after partial ION transection.
Notes: NPY-LI is upregulated in ipsilateral TG (B) compared with the contralateral one (A). Immunofluorescence micrographs show a hypertrophic morphology of Iba1-LI 
in ipsilateral (D and F) vs. contralateral TGs (C and E), counterstaining with PI (red) (E and F). Arrows indicate the NPY-positive neurons (B) and Iba1-positive microglial 
cells (E and F), respectively. Scale bars indicate 50 μm (A and B), 30 μm (C and D), and 25 μm (E and F).








Figure 5 Immunofluorescent micrographs show the expression of biomarkers in contralateral TGs 2 weeks after partial ION transection.
Notes: CGRP-LI (A), SP-LI (B), and pAKT-LI (C) are present in the TG neurons. Arrows indicate positive neurons. Scale bar indicates 50 μm.





In this study, we investigated the expression and regulation 
of several biomarkers in TGs 2 weeks after partial ION 
injury in mice. Following the ION transection and based on 
the NP counting method, dramatic changes of ATF3, Iba1, 
and NPY-LIs were observed but minor to no changes of SP, 
CGRP, nNOS, pAKT, or P2X3 were found in injured TGs 
as compared with contralateral uninjured controls. These 
 findings suggest that distinct mechanisms of adaptation 
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ganglia, and that NPY and activated glial cells may play a 
more important role in trigeminal neuralgia.
Several animal models have been developed for mimick-
ing the injured condition of the human trigeminal nerve.35,36 
Regarding the model of ION injury, the surgery has mostly 
been performed on rats by incising the skin above the 
 unilateral eye.37,38 It is known that many nerve fibers of the 
facial nerve are distributed around eyes, both in superficial 
and deep layers. Therefore, exposing the ION through the 
extraoral approach can inevitably cause damage to the facial 
nerve and other tissues. This extra tissue damage may disturb 
the results of behavioral studies and make it more difficult 
to determine the origin of pain. The model used in this study 
was modified from a previous report, i.e., the surgery was 
carried out intraorally, and the damage of other cranial nerves 
and tissues was greatly limited.27
ATF3 is often used as a marker of damaged neurons, as 
its upregulation indicates subtle damage to the neurons and/
or their axons.39,40 Here, we report that ATF3 is significantly 
upregulated in the ipsilateral TGs vs. the contralateral TGs 
2 weeks after partial injury of ION. ATF3-LI was seen 
in the axotomized neurons, especially in the nucleus and 
sometimes cytoplasm. In addition, most maxillary infra-
orbital neurons were ATF3 positive in the ipsilateral TGs, 
indicating that the axons of these neurons projecting to 
ION were injured following partial ION transection. This 
result further demonstrates that the transection of ION can 
induce a specific nocuous stimulation on the corresponding 
territory innervated by ION afferents, triggering dramatic 
plasticity changes in neuronal receptive fields in the TGs, 
and thus further reflects that the partial ION injury model 
of trigeminal neuralgia in mouse used in this study has 
achieved an injured specificity. These results are in line with 
previous findings that an increase of ATF3-LI was seen in 
the ipsilateral TG neurons, in the ION-innervated region, 
after partial ION ligation.41
Recent studies suggest that microglial cells are vital 
players in the immune response to injury and are largely 
implicated in chronic pain conditions. In most cases, activa-
tion of microglial cells accompanies an increased expression 
of a biomarker, i.e., Iba1.42,43 Moreover, microglial activation 
in the spinal cord contributes to pain hypersensitivity, and it 
has been shown that pharmacological modulation of spinal 
microglial responses can effectively mitigate chronic pain.44 
In the present study, microglial activation accompanying phe-
notype changes was observed in the ipsilateral TGs stained 
with anti-Iba1 antisera following ION injury, indicating that 
activated microglial cells may contribute to the initiation and 
maintenance of neuropathic orofacial pain after trigeminal 
nerve injury.
NPY is widely distributed in the central and peripheral 
nervous systems.45 Both inhibitory and excitatory effects 
have been reported for NPY, depending on which receptor is 
involved.46,47 Our findings that NPY is low in the contralateral 
TGs, but significantly upregulated in the ipsilateral TGs after 
ION injury, are similar to NPY expression in DRG neurons 
after sciatic nerve injury.16,48–50 Our data are also in agreement 
with several previous reports, which indicate that NPY was 
upregulated in TGs following inferior alveolar nerve (IAN) 
injury.49,51,52 A very recent study using a mental nerve injury 
model in rats also showed an increased expression of NPY 
in ipsilateral TGs.53 Thus, upregulation of NPY in injured 
TG neurons indicates a role of NPY in persistent abnormal 
sensations.
GAL, a 29-amino acid peptide, appears to play a role 
in pain modulation.54 GAL and its mRNA are found in 
TGs. After peripheral injury, no change, upregulation, or 
downregulation of GAL in TGs has been reported.16,55,56 Our 
data here are in agreement with previous reports that GAL 
is also expressed in mouse TGs. However, in this study, no 
significant change of GAL was found in injured TGs after 
ION injury, indicating that peripheral nerve injury has less 
influence on GAL synthesis in the TGs than in the DRGs. 
The quantitative differences in GAL expression from these 
studies may be related to variations in time periods, models, 
or species.
It has been established that CGRP and SP have excitatory 
effects on DRG and spinal neurons.57 Regarding regulation 
in the DRGs, peripheral nerve injury reduces the expression 
of CGRP and SP, while peripheral inflammation induced by 
complete Freund’s adjuvant or carrageenan instead increases 
their expressions.58–60 Interestingly, in ferret TGs, the expres-
sion of CGRP and SP was either downregulated after IAN 
transection or showed no change after IAN ligation.13,16 
Here, we report no significant changes of CGRP or SP in 
mouse TGs following partial ION injury. Our data suggest 
that these two neuropeptides may have less impact on ION 
injury-induced abnormal sensations in mice.
Recent studies indicate that purinergic signaling plays 
important roles in physiological and pathophysiological 
processes.61,62 Purinergic receptors are widely distributed in 
mammalian tissues, and these receptors are generally divided 
into three classes: P1, P2X, and P2Y receptors. P2X recep-
tors are ionotropic and ATP sensitive and have been shown 
to be involved in nociceptive processing.63 P2X3 is mainly 
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Neuronal plasticity of TGs in mice following nerve injury
seen in some medium- and large-sized neurons in DRGs and 
can be regulated in different animal models.64–66 In rat TGs, 
transient expression of P2X3 has been detected in response 
to trigeminal nerve injury.64,67 Although the proportion of 
P2X3-positive NPs in mouse TGs remains unchanged at 
2 weeks postoperation in the present study, a role of P2X3 
in mediating the abnormal nociceptive process may still exist 
via enhanced sensitivity of P2X3 receptors as suggested by 
a previous study.63
It is known that nNOS produces nitric oxide (NO) in the 
nervous system.68 As a neuronal neurotransmitter and/or neu-
romodulator, NO is involved in multiple biological processes, 
including modulation of pain.69–71 nNOS is regulated follow-
ing the peripheral nerve injury in both DRGs and TGs,72,73 
and nerve injury-induced hypersensitivity or allodynia can be 
attenuated by a pharmacological inhibition of nNOS.74–76 In 
the present study, we quantified the number of nNOS-positive 
NPs in TGs 2 weeks after ION transection. We did not find 
a significant difference in nNOS expression between the 
ipsilateral and contralateral TGs. In contrast to our findings, 
a significant upregulation of nNOS-IR neurons was seen 
in ipsilateral TGs 7 days after IAN injury, accompanied by 
significantly increased levels of two NO indicators, nitrate 
and nitrite.75 Interestingly, the same group also demonstrated 
that the levels of the two indicators in ipsilateral TGs went 
back to the control levels 14 days after injury, suggesting that 
a transient expression pattern of nNOS exists in injured TGs. 
Furthermore, the dramatic increase of nNOS in TGs 7 days, 
but not 14 days, after injury implies that NO may play a role 
at the early stage of neuropathic pain.
Phosphatidylinositol 3-kinase (PI3-K)/AKT signaling is 
believed to be important for promoting neuronal cell survival 
and axonal outgrowth.77 We have previously investigated 
the expression of pAKT in mouse DRGs and spinal cord 
following sciatic nerve axotomy or carrageenan-induced 
inflammation.5 In normal control animals, pAKT was found 
in both peptidergic and nonpeptidergic DRG neurons. After 
nerve injury, pAKT-IR neurons were seen in ipsilateral DRG 
neurons coexpressed with GAL but not NPY. In addition, 
we also found that the intensity of pAKT-LI in DRGs was 
increased in axotomized animals. To our knowledge, pAKT 
expression in TGs has been much less characterized. In 
this study, we reported that peripheral ION injury did not 
change the proportion of pAKT-positive NPs. However, even 
without quantification, an increased intensity of pAKT-LI 
was detected in the ipsilateral TGs. Our findings suggest 
that there is a PI3-K/AKT signaling pathway in trigeminal 
system.
Conclusion
Trigeminal nerve injury causes marked plasticity of bio-
markers in TGs. Significant changes observed in injured 
TGs suggest that NPY and Iba1 may play crucial roles in 
the pathogenesis of orofacial neuropathic pain, in response 
to peripheral nerve injury.
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